Story
Sinomed Subsidiary's Intracranial Stent System Receives EU MDR Certification

Sinomed (688108.SH) announced that its holding subsidiary, Sinothromb Medical Technology Co., Ltd., has received certification for its self-expanding intracranial drug-eluting stent system. The approval allows the product to bear the CE mark, signifying compliance with the European Union's rigorous Medical Devices Regulation (MDR).
Key Regulatory Milestone
In a company filing, Sinomed confirmed that its independently developed COMETIU™ self-expanding intracranial drug-eluting stent system was certified by an EU notified body. The certification was granted under the Medical Devices Regulation (EU) 2017/745, a comprehensive and stringent framework for medical devices sold in the region.
This certification is a critical step for the company, as the CE mark is a prerequisite for commercializing medical products within the European Union and the European Economic Area. The approval validates the product's design, safety, and performance against high regulatory standards.
Market Access and Future Outlook
AdWhile the CE mark grants access to the European market, Sinomed cautioned that significant commercial uncertainties remain. The company stated that the path to generating revenue involves several subsequent steps, including:
- Completing post-market registration in individual EU member states.
- Establishing effective sales and distribution channels.
- Securing access to hospitals and obtaining reimbursement approvals from payers.
The company emphasized that market development is subject to "great uncertainty" and that future sales could be impacted by factors such as evolving EU regulations, the accumulation of clinical evidence, changes in treatment standards, and currency exchange rate fluctuations.
Sinomed noted it cannot yet predict the specific impact of the certification on its future financial performance. The company also clarified that this approval is applicable only within the EU and EEA and does not guarantee regulatory approval in other countries or regions.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.